Fareeda Al Kandari
Overview
Explore the profile of Fareeda Al Kandari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Usmani S, Murad S, Kandari F, Maraghy M
J Pak Med Assoc
. 2024 Apr;
74(3):597-598.
PMID: 38591310
Krukenberg tumours are a rare form of metastatic tumours of the ovary. They primary site is usually the gastro-intestinal system with the most common being gastric cancer. We present the...
2.
Usmani S, Al-Mohtab S, Albader F, Kandari F
J Pak Med Assoc
. 2023 Feb;
73(1):202-203.
PMID: 36842043
68Ga-DOTA NOC PET-CT imaging has been shown to have high accuracy for the evaluation of neuroendocrine tumours. We report a case of a 3-year-old boy who presented with a right...
3.
Usmani S, Ahmed N, Gnanasegaran G, Kandari F, Marafi F, Bani-Mustafa A, et al.
Acta Oncol
. 2022 Jul;
61(10):1230-1239.
PMID: 35862646
Purpose: This prospective study aims to assess the diagnostic test characteristics of Na[F]F PET/CT for the skeletal staging of cancer in morbidly obese patients compared with Tc-methylene diphosphonate (MDP), whole-body...
4.
Usmani S, Ahmed D, Elhaggracy R, Pinto K, Kandari F
J Pak Med Assoc
. 2022 Mar;
72(3):579-580.
PMID: 35320252
Rosai-Dorman Disease (RDD) is an uncommon benign disorder of proliferative histiocytes. RDD is usually self-remitting yet has been shown to mimic lympho-proliferative disorders clinically as well as on imaging studies....
5.
Usmani S, Ahmed D, Hamadah A, Kandari F
J Pak Med Assoc
. 2022 Feb;
71(1(B)):388-389.
PMID: 35157690
18F-Fluorodeoxyglucose (FDG) PET-CT is an excellent imaging modality for the evaluation of Non-Hodgkin lymphoma. We report a case of 65-year-old man with haematuria; rectal examination and ultrasonography revealed prostate mass....
6.
Usmani S, Kandari F, Alrekhais I, N Khalaf S, Ahmed N
Clin Nucl Med
. 2021 Oct;
47(2):e213-e214.
PMID: 34653057
Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy with 177Lu-PSMA-617 has shown promising results in patients with metastasized castration-resistant prostate cancer. We report a case of a 74-year-old man with metastatic prostate...
7.
Muzaffar S, Ahmed N, Rahman U, Kandari F, Usmani S
Indian J Nucl Med
. 2021 May;
36(1):90-91.
PMID: 34040311
Ga-prostate-specific membrane antigen (Ga-PSMA) is expressed in the endothelium of tumor-associated neovasculature of various solid malignancies possibly due to tumor-associated angiogenic factors and endothelial cell sprouting. We report a case...
8.
Usmani S, Ahmed N, Gnanasegaran G, Rasheed R, Marafi F, Alnaaimi M, et al.
Br J Radiol
. 2021 Feb;
94(1120):20210043.
PMID: 33571003
Objective: A new Bayesian penalized likelihood reconstruction algorithm for positron emission tomography (PET) (Q.Clear) is now in clinical use for fludeoxyglucose (FDG) PET/CT. However, experience with non-FDG tracers and in...
9.
Usmani S, Rasheed R, Kandari F, Ahmed N
Clin Nucl Med
. 2021 Jan;
46(8):661-663.
PMID: 33512948
68Ga-PSMA is an excellent radiotracer for both staging and detection of recurrence in prostate cancer, but it can also be useful in other solid tumors due to tumor-associated angiogenic factors...
10.
Usmani S, Ahmed N, Gnanasegaran G, Musbah A, Kandari F, Van den Wyngaert T
J Nucl Med Technol
. 2020 Dec;
49(2):150-155.
PMID: 33380519
F-NaF PET/CT has a rapid single-pass extraction and fast clearance from soft tissues, resulting in a good target-to-background ratio. This study aimed to establish the optimum acquisition time and dosimetry...